ES8303091A1 - Un procedimiento para la preparacion de una nueva formulacion de bacampicilina. - Google Patents

Un procedimiento para la preparacion de una nueva formulacion de bacampicilina.

Info

Publication number
ES8303091A1
ES8303091A1 ES504905A ES504905A ES8303091A1 ES 8303091 A1 ES8303091 A1 ES 8303091A1 ES 504905 A ES504905 A ES 504905A ES 504905 A ES504905 A ES 504905A ES 8303091 A1 ES8303091 A1 ES 8303091A1
Authority
ES
Spain
Prior art keywords
suspension
acid addition
addition salt
bacampicillin
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES504905A
Other languages
English (en)
Other versions
ES504905A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8303091A1 publication Critical patent/ES8303091A1/es
Publication of ES504905A0 publication Critical patent/ES504905A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE FORMULACIONES DE BACAMPICILINA, CONSTITUIDA POR UN POLVO, QUE POR ADICION DE AGUA FORMA UNA SUSPENSION FARMACEUTICA DE MOCROCAPSULAS. CONSISTE EN FLUIDIFICAR EN UN LECHO UNA SAL DE ADICION DE ACIDO DE BACAMPICILINA SOLUBLE EN AGUA; PULVERIZAR SOBRE EL LECHO UNA DISOLUCION O SUSPENSION CONSTITUIDA POR CELULOSA Y POR UN MATERIAL DE CARGA, SOLUBLE EN AGUA O PERMEABLE A ELLA; Y COMBINAR LAS MICROCAPSULAS ASI FORMADAS CON INGREDIENTES, TALES QUE EL PH DEL MEDIO SUSPENSOR ACUOSO EN LA SUSPENSION NO ES INFERIOR A 6,9. ESTAS FORMULACIONES TIENEN APLICACIONES EN FARMACOLOGIA PARA LA ADMINISTRACION ORAL DE DOSIS MULTIPLES.
ES504905A 1980-08-22 1981-08-21 Un procedimiento para la preparacion de una nueva formulacion de bacampicilina. Granted ES504905A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/180,537 US4321253A (en) 1980-08-22 1980-08-22 Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration

Publications (2)

Publication Number Publication Date
ES8303091A1 true ES8303091A1 (es) 1983-02-01
ES504905A0 ES504905A0 (es) 1983-02-01

Family

ID=22660812

Family Applications (1)

Application Number Title Priority Date Filing Date
ES504905A Granted ES504905A0 (es) 1980-08-22 1981-08-21 Un procedimiento para la preparacion de una nueva formulacion de bacampicilina.

Country Status (41)

Country Link
US (1) US4321253A (es)
JP (1) JPS5775986A (es)
KR (1) KR860000513B1 (es)
AR (1) AR227201A1 (es)
AT (1) AT370994B (es)
AU (1) AU529965B2 (es)
BE (1) BE890028A (es)
BG (1) BG42000A3 (es)
CA (1) CA1137414A (es)
CH (1) CH650674A5 (es)
CS (1) CS225845B2 (es)
DD (1) DD201644A5 (es)
DE (1) DE3132614C2 (es)
DK (1) DK158971C (es)
DZ (1) DZ315A1 (es)
ES (1) ES504905A0 (es)
FI (1) FI72647C (es)
FR (1) FR2488798A1 (es)
GB (1) GB2082539B (es)
GR (1) GR74983B (es)
HK (1) HK43786A (es)
HU (1) HU188679B (es)
IE (1) IE51506B1 (es)
IL (1) IL63617A (es)
IN (1) IN156538B (es)
IT (1) IT1138161B (es)
KE (1) KE3626A (es)
LU (1) LU83572A1 (es)
MX (1) MX5731A (es)
MY (1) MY8600597A (es)
NL (1) NL191978C (es)
NO (1) NO154821C (es)
NZ (1) NZ198106A (es)
PH (1) PH17125A (es)
PL (1) PL232141A1 (es)
PT (1) PT73555B (es)
RO (1) RO82679B (es)
SE (1) SE448819B (es)
SU (1) SU1364226A3 (es)
YU (1) YU43985B (es)
ZA (1) ZA815793B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
EP0111560A4 (en) * 1982-06-14 1987-02-03 Key Pharma ASPIRINE WITH CONTINUOUS LEVEL.
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
EP0113373B1 (en) * 1982-07-09 1991-08-28 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
AU569277B2 (en) * 1983-03-03 1988-01-28 Dow Chemical Company, The Aqueuos dispersion of water-insoluble organophilic cellulose ether for sustained release of active agents
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ES2099438T3 (es) * 1992-04-30 1997-05-16 Schering Corp Polvo seco y estable de cefalosporina hidratada para formulacion de suspension oral.
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
IN191482B (es) * 1999-03-19 2003-12-06 Ranbaxy Lab Ltd
JP4711478B2 (ja) * 1999-08-13 2011-06-29 旭化成ケミカルズ株式会社 味がマスクされた薬物
US20050037086A1 (en) * 1999-11-19 2005-02-17 Zycos Inc., A Delaware Corporation Continuous-flow method for preparing microparticles
AU784340B2 (en) 1999-12-23 2006-03-16 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
EP1276470B1 (en) 2000-04-20 2007-05-02 Novartis AG Taste masking coating composition
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
CA2410052A1 (en) * 2000-06-02 2001-12-13 Zycos Inc. Delivery systems for bioactive agents
FR2822834B1 (fr) * 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
US20030096791A1 (en) * 2001-05-31 2003-05-22 Cima Labs Inc. Taste masking of highly water-soluble drugs
KR20030015655A (ko) * 2001-08-17 2003-02-25 한미약품공업 주식회사 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
IL164222A0 (en) 2002-04-09 2005-12-18 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
IL164221A0 (en) * 2002-04-09 2005-12-18 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
US7244765B2 (en) * 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using
FR2885526B1 (fr) * 2005-05-13 2007-07-27 Flamel Technologies Sa Medicament oral a base d'inhibiteur de pompe a protons
US20180177820A1 (en) * 2015-10-13 2018-06-28 Techno Guard Co. Ltd. Protective composition for gastrointestinal mucosa

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549746A (en) * 1967-11-02 1970-12-22 Bristol Myers Co Antibiotic composition
US3873521A (en) * 1970-09-17 1975-03-25 Astra Laekemedel Ab Esters of {60 -amino penicillins
ZA718014B (en) 1970-12-23 1972-08-30 Beecham Group Ltd Pharmaceutical formulations
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
GB1455296A (en) * 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
GB1479655A (en) 1974-03-08 1977-07-13 Beecham Group Ltd Antibiotic preparations
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
ZA793934B (en) * 1978-08-04 1980-07-30 Beecham Group Ltd Powders
JPS57105316A (en) * 1980-12-23 1982-06-30 Hitachi Cable Ltd Method of fitting heat-shrinkable tube

Also Published As

Publication number Publication date
DE3132614C2 (de) 1985-08-22
BE890028A (fr) 1982-02-22
FI72647C (fi) 1987-07-10
PT73555A (en) 1981-09-01
DD201644A5 (de) 1983-08-03
NL191978C (nl) 1996-12-03
PT73555B (en) 1983-07-14
DK158971B (da) 1990-08-13
DK158971C (da) 1991-01-07
IE51506B1 (en) 1987-01-07
KR830005850A (ko) 1983-09-14
IE811911L (en) 1982-02-22
DE3132614A1 (de) 1982-05-19
MX5731A (es) 1993-11-01
CS225845B2 (en) 1984-02-13
NZ198106A (en) 1983-12-16
IT1138161B (it) 1986-09-17
ZA815793B (en) 1982-08-25
PL232141A1 (es) 1982-03-15
BG42000A3 (en) 1987-09-15
JPS5775986A (en) 1982-05-12
SU1364226A3 (ru) 1987-12-30
CH650674A5 (fr) 1985-08-15
SE8104974L (sv) 1982-02-23
NO154821C (no) 1987-01-07
GR74983B (es) 1984-07-12
IL63617A0 (en) 1981-11-30
AT370994B (de) 1983-05-25
DK372181A (da) 1982-02-23
HK43786A (en) 1986-06-20
NO154821B (no) 1986-09-22
GB2082539A (en) 1982-03-10
LU83572A1 (fr) 1982-04-14
RO82679B (ro) 1984-07-30
YU201781A (en) 1984-04-30
RO82679A (ro) 1984-05-23
MY8600597A (en) 1986-12-31
AU7441681A (en) 1982-04-01
FR2488798B1 (es) 1985-01-11
GB2082539B (en) 1984-01-18
FI812574L (fi) 1982-02-23
IT8123587A0 (it) 1981-08-20
AU529965B2 (en) 1983-06-30
NL8103902A (nl) 1982-03-16
FR2488798A1 (fr) 1982-02-26
US4321253A (en) 1982-03-23
CA1137414A (en) 1982-12-14
AR227201A1 (es) 1982-09-30
IN156538B (es) 1985-08-31
ES504905A0 (es) 1983-02-01
KE3626A (en) 1986-05-16
ATA362781A (de) 1982-10-15
NO812827L (no) 1982-02-23
JPH0248525B2 (es) 1990-10-25
KR860000513B1 (ko) 1986-05-02
YU43985B (en) 1990-02-28
NL191978B (nl) 1996-08-01
FI72647B (fi) 1987-03-31
HU188679B (en) 1986-05-28
SE448819B (sv) 1987-03-23
PH17125A (en) 1984-06-01
IL63617A (en) 1984-11-30
DZ315A1 (fr) 2004-09-13

Similar Documents

Publication Publication Date Title
ES8303091A1 (es) Un procedimiento para la preparacion de una nueva formulacion de bacampicilina.
MY103525A (en) Pharmaceutical composition comprising cefuroxime axetil
HK1040631A1 (en) Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues.
EP0390369A3 (en) Orally administrable ibuprofen compositions
AU1874788A (en) Pediatric ibuprofen formulations
CA2215329A1 (en) Colorectal chemoprotective composition and method for preventing colorectal cancer
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
NZ234143A (en) Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
NO863061L (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
DE3766200D1 (de) L-dopa enthaltendes arzneimittel.
EP0397147A3 (en) Stable solutions of rebeccamycin analog and preparation thereof
MY101747A (en) Dihydroorotic acids derivative, processes for preparing the same
NO841372L (no) Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig regulert frigjoering
JPS57106611A (en) Coating remedy
KR900701263A (ko) 이보파민의 수용성 산 부가 염을 포함하는 안과용 약학 조성물
MY107599A (en) Sucralfate suspension compounds.
IL74956A0 (en) N-(3-phenylmethyl thio-1-oxopropyl)aminoacetic acid derivatives,their preparation and pharmaceutical compositions containing them
ES8505343A1 (es) Procedimiento para preparar derivados de dibenzo
IL83606A0 (en) Derivatives of 2,2-dimethyl-cyclopropanecarboxylic acid,their preparation and their use as insecticides and acaricides
TH2950B (th) สารแขวนลอยซูครัลเฟท
EP0153171A3 (en) New 2-hydroxyethyl-trimethylammonium salt of 1-ethyl-3-carboxy-4-oxo-6,7-methylenedioxy-1,4-dihydroquinoline, process for the preparation thereof and pharmaceutical composition containing it
TH3206A (th) สารแขวนลอยซูครัลเฟท
ZA852923B (en) N-(3-phenylmethylthio-1-oxoporpyl)aminoacetic acid derivatives,their preparation and pharmaceutical compositions containing them
IL78136A (en) Indole derivatives,acid addition salts thereof,process for their preparation and pharmaceutical compositions comprising them
BG42833A3 (en) Method for preparing of 1, 3- bis (dimethylamino)- 2- propyl- 4- chlorphenynoxyacetate

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20100623